{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:23:24Z","timestamp":1769631804679,"version":"3.49.0"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer Pharmaceuticals","doi-asserted-by":"publisher","award":["WI196547"],"award-info":[{"award-number":["WI196547"]}],"id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","award":["RSIG-051"],"award-info":[{"award-number":["RSIG-051"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","award":["GCP121-A"],"award-info":[{"award-number":["GCP121-A"]}],"id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["85000782"],"award-info":[{"award-number":["85000782"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Insulin-like growth factor 1 (IGF-1) is the standard biochemical marker for the diagnosis and treatment control of acromegaly and growth hormone deficiency (GHD). However, its limitations necessitate the screening for new specific and sensitive biomarkers. The elonginB\/C-cullin5-SOCS-box-complex (ECS-complex) (an intracellular five-protein complex) is stimulated by circulating growth hormone (GH) and regulates GH receptor levels through a negative feedback loop. It mediates the cells\u2019 sensitivity for GH and therefore, represents a potent new biomarker for those diseases. In this study, individual ECS-complex proteins were measured in whole blood samples of patients with acromegaly (n = 32) or GHD (n = 12) via ELISA and compared to controls. Hierarchical clustering of the results revealed that by combining the three ECS-complex proteins suppressor of cytokine signaling 2 (SOCS2), cullin-5 and ring-box protein 2 (Rbx-2), 93% of patient samples could be separated from controls, despite many patients having a normal IGF-1 or not receiving medical treatment. SOCS2 showed the best individual diagnostic performance with an overall accuracy of 0.93, while the combination of the three proteins correctly identified all patients and controls. This resulted in perfect sensitivity and specificity for all patient groups, which demonstrates potential benefits of the ECS-complex proteins as clinical biomarkers for the diagnostics of GH-related diseases and substantiates their important role in GH metabolism.<\/jats:p>","DOI":"10.3390\/biomedicines9020201","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T21:35:42Z","timestamp":1613597742000},"page":"201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The ElonginB\/C-Cullin5-SOCS-Box-Complex Is a Potential Biomarker for Growth Hormone Disorders"],"prefix":"10.3390","volume":"9","author":[{"given":"Wilhelm","family":"Gossing","sequence":"first","affiliation":[{"name":"Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences, 15745 Wildau, Germany"},{"name":"Department of Endocrinology and Metabolism, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Radke","sequence":"additional","affiliation":[{"name":"Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences, 15745 Wildau, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Biering","sequence":"additional","affiliation":[{"name":"Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences, 15745 Wildau, Germany"},{"name":"Praxis an der Kaisereiche, Innere Medizin, Endokrinologie, Diabetologie, 12159 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Diederich","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"},{"name":"MVZ Medicover Berlin-Mitte, Innere Medizin, Endokrinologie, Andrologie, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9063-2682","authenticated-orcid":false,"given":"Marcus","family":"Frohme","sequence":"additional","affiliation":[{"name":"Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences, 15745 Wildau, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/2359-3997000000195","article-title":"Incidence and prevalence of clinically relevant pituitary adenomas: Retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina","volume":"60","author":"Day","year":"2016","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.endonu.2012.09.010","article-title":"Epidemiolog\u00eda de la acromegalia en Espa\u00f1a. [Epidemiology of acromegaly in Spain]","volume":"60","author":"Sesmilo","year":"2013","journal-title":"Endocrinol. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11102-015-0701-2","article-title":"Incidence and prevalence of acromegaly in a large US health plan database","volume":"19","author":"Burton","year":"2016","journal-title":"Pituitary"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-10-0465","article-title":"Increased prevalence of acromegaly in a highly polluted area","volume":"163","author":"Ragonese","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: A nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3171\/jns.1981.54.2.0228","article-title":"Incidental pituitary adenomas","volume":"54","author":"Parent","year":"1981","journal-title":"J. Neurosurg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_11","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly","volume":"83","author":"Swearingen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.12688\/f1000research.7043.1","article-title":"Recent advances in the management of acromegaly","volume":"4","author":"Ntali","year":"2015","journal-title":"F1000Research"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: A metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright","year":"1970","journal-title":"Q. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients\u20142009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tem.2004.06.004","article-title":"Alternatives to growth hormone stimulation testing in children","volume":"15","author":"Badaru","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-71-5-1127","article-title":"Reproducibility of growth hormone testing procedures: A comparison between 24-hour integrated concentration and pharmacological stimulation","volume":"71","author":"Zadik","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00431-014-2406-3","article-title":"Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: A systematic review with meta-analysis","volume":"174","author":"Shen","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1530\/EC-14-0098","article-title":"Metabolomics: A tool for the diagnosis of GH deficiency and for monitoring GH replacement?","volume":"3","author":"Norstedt","year":"2014","journal-title":"Endocr. Connect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: Relationship to population-based normal values, body composition and insulin tolerance test","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"ref_21","first-page":"2013","article-title":"Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19\u201382 years, in relation to those in healthy subjects","volume":"84","author":"Hilding","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2265.2007.02836.x","article-title":"Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice","volume":"67","author":"Pokrajac","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: Comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","author":"Murray","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4158\/EP161407.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: Update on growth hormone stimulation testing and proposed revised cut-point for the glucagon stimulation test in the diagnosis of adult growth hormone deficiency","volume":"22","author":"Yuen","year":"2016","journal-title":"Endocr. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000509840","article-title":"A Bayesian approach to diagnose growth hormone deficiency in children: Insulin-like growth factor type 1 is valuable for screening and IGF-binding protein type 3 for confirmation","volume":"93","author":"Vasques","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"ref_27","first-page":"800","article-title":"The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy","volume":"72","author":"Novoa","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1172\/JCI200417763","article-title":"Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1\u2013deficient mice","volume":"113","author":"Yakar","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000512336","article-title":"Diagnostic value of serum acid-labile subunit alone and in combination with IGF-I and IGFBP-3 in the diagnosis of growth hormone deficiency","volume":"93","author":"Ertl","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-12-1045","article-title":"Soluble \u03b1-klotho: A novel serum biomarker for the activity of GH-producing pituitary adenomas","volume":"168","author":"Neidert","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-17-0844","article-title":"Decorin, a growth hormone-regulated protein in humans","volume":"178","author":"Bahl","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2011-0197","article-title":"Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients","volume":"96","author":"Jorgensen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","first-page":"1505","article-title":"Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: A double blind, placebo-controlled study","volume":"85","author":"Longobardi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.2012.04346.x","article-title":"What is active acromegaly and which parameters do we have?","volume":"76","author":"Neggers","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2018.03.005","article-title":"Biomarkers of GH action in children and adults","volume":"40","author":"Schilbach","year":"2018","journal-title":"Growth Horm. IGF Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/me.2005-0170","article-title":"Negative regulation of growth hormone receptor signaling","volume":"20","author":"Greenhalgh","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI200522710","article-title":"SOCS2 negatively regulates growth hormone action in vitro and in vivo","volume":"115","author":"Greenhalgh","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/me.2006-0541","article-title":"Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor","volume":"21","author":"Uyttendaele","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Vesterlund, M., Zadjali, F., Persson, T., Nielsen, M.L., Kessler, B.M., Norstedt, G., and Flores-Morales, A. (2011). The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025358"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1210\/endo.140.8.6878","article-title":"Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat","volume":"140","author":"Sahlin","year":"1999","journal-title":"Endocrinology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hochberg, I., Tran, Q.T., Barkan, A.L., Saltiel, A.R., Chandler, W.F., and Bridges, D. (2015). Gene expression signature in adipose tissue of acromegaly patients. PLoS ONE, 10.","DOI":"10.1186\/1471-2105-15-S10-P28"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1101\/gad.1252404","article-title":"VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases","volume":"18","author":"Kamura","year":"2004","journal-title":"Genes Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"ref_44","first-page":"984","article-title":"Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry","volume":"79","author":"Badolato","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","first-page":"23","article-title":"ECS-Komplex\u2014Ein neuer Biomarker bei Wachstumshormon-st\u00f6rungen?","volume":"20","author":"Gossing","year":"2016","journal-title":"Wiss. Beitr\u00e4ge"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2307\/2529262","article-title":"A generalization of the probit and logit methods for dose response curves","volume":"32","author":"Prentice","year":"1976","journal-title":"Biometrics"},{"key":"ref_47","first-page":"117","article-title":"Detection of outliers in gene expression data using expressed robust T test","volume":"10","year":"2016","journal-title":"Malays. J. Math. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: Which algorithms implement Ward\u2019s criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J. Classif."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kuncheva, L. (2004). Combining Pattern Classifiers: Methods and Algorithms, Wiley-Interscience. [1st ed.].","DOI":"10.1002\/0471660264"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.01838","article-title":"The \u2018bio-assay\u2019 quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations","volume":"152","author":"Bonapart","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1210\/en.2004-0061","article-title":"Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro","volume":"145","author":"Leong","year":"2004","journal-title":"Endocrinology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(99)00681-X","article-title":"Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction","volume":"453","author":"Favre","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"40181","DOI":"10.1074\/jbc.C200450200","article-title":"Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling","volume":"277","author":"Greenhalgh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-14-0292","article-title":"Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2\u2212\/\u2212 mice","volume":"223","author":"Dobie","year":"2014","journal-title":"J. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","article-title":"Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant","volume":"93","author":"Neggers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:14Z","timestamp":1760160314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["biomedicines9020201"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9020201","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}